Abstract
The developments in the area of inhibition of different serine enzymes by βlactams have been reviewed recently [1]. Since then, the following advances have been made: development of synthetic methodology for the preparation of enantiomerically pure lactams, whose inhibiting properties have been previously established; preparation of novel antibacterial cephams; synthesis of prodrugs containing dual inhibitors of PBPs and βlactamases; and the discovery of monocyclic βlactams, whose mode of action and structure-activity profiles differ dramatically from those of traditional βlactam drugs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.